Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$34,096,996
+$989,554 QoQ
Shares Held
134,256
-0.9% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
2.93%
of 13F equity value
Holder Rank
#558
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Colonial Trust Advisors holds $80,602,138 across 14 Drug Manufacturers - General names. JNJ ranks #2 (42.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
35,773 | $42,907,212 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
134,256 | $34,096,996 | |
| 3 | MRK |
Merck & Co., Inc.
|
8,658 | $1,112,553 | |
| 4 | AMGN |
Amgen Inc
|
2,503 | $906,386 | |
| 5 | ABBV |
AbbVie Inc.
|
3,104 | $781,090 | |
| 6 | NVS |
Novartis AG
|
1,390 | $217,840 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,467 | $199,768 | |
| 8 | NVO |
Novo Nordisk A S
|
3,581 | $171,673 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,096,996 | 134,256 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $33,107,442 | 135,442 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $28,239,983 | 136,458 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $24,574,454 | 132,534 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $20,212,491 | 132,324 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $21,437,141 | 129,264 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $18,009,383 | 124,529 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $20,804,290 | 128,374 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $18,167,834 | 124,301 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $19,600,531 | 123,905 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $19,468,675 | 124,210 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $19,633,222 | 126,056 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $21,502,372 | 129,908 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $20,352,120 | 131,304 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $23,098,930 | 130,761 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $21,406,857 | 131,041 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $22,178,631 | 124,943 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $22,115,468 | 124,784 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $21,289,490 | 124,449 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $20,232,720 | 125,280 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $20,853,942 | 126,587 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $20,904,498 | 127,195 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $20,065,320 | 127,496 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $18,897,933 | 126,934 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $17,847,353 | 126,910 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $16,323,455 | 124,483 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||